In our research, IL-17 levels were significantly higher in patients with both psoriasis and metabolic syndrome compared to those with only psoriasis, which suggest a more pronounced inflammatory response, potentially establishing a connection between the systemic inflammation associated with metabolic syndrome and the localized inflammation characteristic of psoriasis [59]. The gene discussed is IL17A; the disease is psoriasis.